Blog - Healthed

Podcasts

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

Neurology

Going Viral

0.5 EA, 0.5 RP

COVID and the Brain

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

Expert/s: A/Prof Lucette Cysique, Dr Clare Ramsden

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

COVID Update – ATAGI, Fourth booster, Novavax, Post-COVID heart risk

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

Expert/s: Prof Nigel Crawford

Diabetes and metabolism, Surgery

Lectures

Bariatric surgery update – Which option for which patient?

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

Expert/s: Prof John Dixon

Cardiology

Lectures

Recognising and managing DOAC complications

Insight and understanding into how to identify and assess complications of DOACs, and, importantly, how adverse effects of DOACs can be best managed.

Expert/s: Prof Andrew Sindone AM

Infectious diseases

Lectures

Update on shingles vaccination – Lecture

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

Expert/s: Prof Tony Cunningham AO

Infectious diseases, Respiratory and sleep

Going Viral

0.5 EA, 0.5 RP

COPD, COVID and other jabs

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Expert/s: Prof Christine Jenkins

Infectious diseases, Travel medicine

Going Viral

0.5 EA, 0.5 RP

Why Africa may never be fully vaccinated – Stories from the frontline

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

Expert/s: Lindsay Thitchener

Neurology

Clinical Takeaway

0.5 EA, 0.5 RP

Easy to miss red flags for ADHD and other neurodevelopment disorders

The diagnosis of a neurodevelopmental disorder is just the beginning of management

Expert/s: Dr Renee Testa, Dr Sarah Seth

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

Omicron – what’s new?

Boosters and other recent developments

Expert/s: Prof Nancy Baxter

Psychiatry

Lectures

The art and science of antipsychotic prescribing – Lecture CPD 1 point

The rates of remission and recovery after a single schizophrenic episode are good (~80%), but the rates decline with each subsequent episode.

Expert/s: Dr Prachi Brahmbhatt

Oncology

Lectures

COVID, cancer patients and vaccination – Lecture

Being aware of the COVID-related issues among cancer patients allows health professionals to actively address concerns and barriers

Expert/s: Prof John Boyages AM

Haematology

Clinical Takeaway

0.5 EA, 0.5 RP

Haemochromatosis – Diagnosis and management

Whom should you suspect and whom should we screen for this common condition?

Expert/s: Prof John Olynyk

COVID and the Brain

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

Expert/s: A/Prof Lucette Cysique, Dr Clare Ramsden

Going Viral

Neurology

COVID Update – ATAGI, Fourth booster, Novavax, Post-COVID heart risk

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

Expert/s: Prof Nigel Crawford

Going Viral

Infectious diseases

Bariatric surgery update – Which option for which patient?

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

Expert/s: Prof John Dixon

Lectures

Diabetes and metabolism, Surgery

Recognising and managing DOAC complications

Insight and understanding into how to identify and assess complications of DOACs, and, importantly, how adverse effects of DOACs can be best managed.

Expert/s: Prof Andrew Sindone AM

Lectures

Cardiology

Update on shingles vaccination – Lecture

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

Expert/s: Prof Tony Cunningham AO

Lectures

Infectious diseases

COPD, COVID and other jabs

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Expert/s: Prof Christine Jenkins

Going Viral

Infectious diseases, Respiratory and sleep

Why Africa may never be fully vaccinated – Stories from the frontline

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

Expert/s: Lindsay Thitchener

Going Viral

Infectious diseases, Travel medicine

Easy to miss red flags for ADHD and other neurodevelopment disorders

The diagnosis of a neurodevelopmental disorder is just the beginning of management

Expert/s: Dr Renee Testa, Dr Sarah Seth

Clinical Takeaway

Neurology

Omicron – what’s new?

Boosters and other recent developments

Expert/s: Prof Nancy Baxter

Going Viral

Infectious diseases

The art and science of antipsychotic prescribing – Lecture CPD 1 point

The rates of remission and recovery after a single schizophrenic episode are good (~80%), but the rates decline with each subsequent episode.

Expert/s: Dr Prachi Brahmbhatt

Lectures

Psychiatry

COVID, cancer patients and vaccination – Lecture

Being aware of the COVID-related issues among cancer patients allows health professionals to actively address concerns and barriers

Expert/s: Prof John Boyages AM

Lectures

Oncology

Haemochromatosis – Diagnosis and management

Whom should you suspect and whom should we screen for this common condition?

Expert/s: Prof John Olynyk

Clinical Takeaway

Haematology

Podcasts

Filter results

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

Insight and understanding into how to identify and assess complications of DOACs, and, importantly, how adverse effects of DOACs can be best managed.

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

The diagnosis of a neurodevelopmental disorder is just the beginning of management

Boosters and other recent developments

The rates of remission and recovery after a single schizophrenic episode are good (~80%), but the rates decline with each subsequent episode.

Being aware of the COVID-related issues among cancer patients allows health professionals to actively address concerns and barriers

Whom should you suspect and whom should we screen for this common condition?

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

Insight and understanding into how to identify and assess complications of DOACs, and, importantly, how adverse effects of DOACs can be best managed.

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

The diagnosis of a neurodevelopmental disorder is just the beginning of management

Boosters and other recent developments

The rates of remission and recovery after a single schizophrenic episode are good (~80%), but the rates decline with each subsequent episode.

Being aware of the COVID-related issues among cancer patients allows health professionals to actively address concerns and barriers

Whom should you suspect and whom should we screen for this common condition?

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Gallbladder – When surgery is or is not needed" lecture

Tuesday 26th May, 7pm - 9pm AEST

Speaker

Dr David Yeo

Specialist Upper GI, Hepatobiliary and Bariatric Surgeon; Chris O’Brien Lifehouse, RPA and St George Hospitals

In this talk, surgeon, Dr David Yeo will answer these and many other real-world questions related to this common condition and provide an update on the latest recommendations for the assessment, investigation and management of gallbladder disease.